Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Biosensing Instrument Wins Prestigious R&D 100 Award

Biosensing Instrument,Inc.
Posted on: 15 Nov 16

Biosensing Instrument Inc. (BI) announced today that the BI-4500 received the prestigious R&D 100 Award from R&D Magazine for innovative products recently introduced to the market. The awards were announced at the 54th Annual R&D 100 Awards and Technology Conference on Nov. 3 in Washington, D.C.

“We are thrilled with this honor,” said Dr. Tianwei Jing, President of BI and third time R&D 100 winner. “We have a long track record of introducing novel technology to the market, and this award is a testimony of BI’s commitment to advance biosensing research.”

The BI-4500 is a 5-Channel Label Free Surface Plasmon Resonance System used in the life science basic and applied life research to study the interactions between molecules in real time without the aid of fluorescent labels. The systems are utilized to measure biomolecular kinetics, molecular adsorption, concentration of biomolecules and strength of molecular interactions. With the SPR analysis modules, researchers can perform various applications such as electrochemistry and gas phase SPR with ease.

Often referred to as the “Oscars of Invention,” the annual R&D 100 Awards celebrate the most significant technology inventions of the past year. The R&D Top 100 list was established in 1963 and over the past 53 years, R&D 100 has recognized various revolutionary products in the areas of analytical test equipment, new materials, high-energy physics, biomedical products, software and biotechnology.

Click here for the full list of winners.

About Biosensing Instrument

Biosensing Instrument, Inc. (BI) is a privately held company based in Tempe, Arizona and a technology leader in label-free molecular interaction analysis applications. The BI solutions are based on the Surface Plasmon Resonance (SPR) technology, and the instruments are high performance, modular and cost-effective. They are used in academic and biopharmaceutical research for the measurement of affinity and kinetics of small or large biomolecules. Application areas include life sciences, drug discovery, antibody characterization, biosensors and electrochemistry. Information about BI can be found at www.biosensingUSA.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20161115005058/en/

Business Wire
www.businesswire.com

Last updated on: 15/11/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.